Evaluation of Gestational Diabetes Mellitus Risk in South Indian Women Based on MTHFR (C677T) and FVL (G1691A) Mutations by Imran Ali Khan et al.
ORIGINAL RESEARCH
published: 05 May 2015
doi: 10.3389/fped.2015.00034
Edited by:
Marijana Pericic Salihovic,
Institute for Anthropological Research,
Croatia
Reviewed by:
Suresh Kumar Chitta,
Sri Krishnadevaraya University, India
Shaik Abdul Nabi,
University of Hyderabad, India
Tatjana Skaric-Juric,
Institute for Anthropological Research,
Croatia
*Correspondence:
Pragna Rao,
Department of Biochemistry,
Kasturba Medical College, Manipal
University, Manipal, Karnataka, India
drpragnarao@gmail.com
Specialty section:
This article was submitted to Genetic
Disorders, a section of the journal
Frontiers in Pediatrics
Received: 26 November 2014
Accepted: 07 April 2015
Published: 05 May 2015
Citation:
Khan IA, Shaik NA, Kamineni V, Jahan
P, Hasan Q and Rao P (2015)
Evaluation of gestational diabetes
mellitus risk in South Indian women
based on MTHFR (C677T) and FVL
(G1691A) mutations.
Front. Pediatr. 3:34.
doi: 10.3389/fped.2015.00034
Evaluation of gestational diabetes
mellitus risk in South Indian women
based on MTHFR (C677T) and FVL
(G1691A) mutations
Imran Ali Khan 1,2,3, Noor Ahmad Shaik 4, Vasundhara Kamineni 5, Parveen Jahan 3,
Qurratulain Hasan 1,2 and Pragna Rao 6*
1 Department of Genetics and Molecular Medicine, Kamineni Hospitals, Hyderabad, India, 2 Department of Genetics, Vasavi
Medical and Research Center, Hyderabad, India, 3 Department of Genetics and Biotechnology, Osmania University,
Hyderabad, India, 4 Department of Genetic Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
Arabia, 5 Department of Gynecology and Obstetrics, Kamineni Hospitals, Hyderabad, India, 6 Department of Biochemistry,
Kasturba Medical College, Manipal University, Manipal, Karnataka, India
We aimed to scrutinize the extent to which single amino acid substitutions in the
MTHFR and factor V Leiden (FVL) genes affect the risk of gestational diabetes mellitus
(GDM) in pregnant women of South Indian descendant. This case–control study was
implemented once the ethical approval has been obtained. Overall, 237 women were
recruited in this study: 137 had been diagnosed with GDM and the remaining 100
women were used as normal controls or non-GDM. The diagnosis of GDMwas confirmed
with biochemical analysis, i.e., GCT and oral glucose tolerance tests. Five milliliters of
peripheral blood was collected and used for biochemical and molecular analyses. DNA
was isolated, and genotyping for MTHFR (C677T) and FVL (G1691A) mutations was
performed using PCR–RFLP. FVL (G1691A) locus was not polymorphic in the investigated
sample. There was no significant difference in the allele and genotype frequencies of
C677T polymorphism between GDM and non-GDM women (p=0.8892).
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Introduction
Gestational diabetes mellitus (GDM) is among the most common metabolic disorders affecting
pregnant women characterized by glucose intolerance of variable severity, which is usually detected
at the onset of or during pregnancy (1). GDM is treated by insulin or dietary modifications. It
typically develops during the secondary trimester of pregnancy and resolves after the delivery (2).
The risk of GDM women is intensified by advanced maternal age, ancestral disparities, obesity, and
a family history of diabetes (3); however, the exact etiology is unknown due to limited knowledge
of genetic factors (4). GDM patients are at increased risk of gestational hypertension, pre-eclampsia
during pregnancy, and type 2 diabetes (T2DM), as well as metabolic syndromes in later life (5).
Pregnant women with a history of GDM are at greater risk of developing T2DM, and a family
history of diabetes predisposes pregnant women to GDM (6). Elevated fasting glucose and insulin
levels are observed in women who do not have GDM but have a family history of the disease (7).
Individuals of Asian descents have two- to sevenfold greater risk of developing GDM than their
Caucasian counterparts in developed countries (8). Various epidemiological studies have reported
an association between metabolic disorders and risk of developing T2DM or GDM, and numerous
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efforts have been made to identify pathogenic mutations in
nuclear and mitochondrial genomes that are linked to both types
of diabetes. Various susceptibility loci have been identified by
linkage analyses and genome-wide association studies (1).
The methylenetetrahydrofolate reductase (MTHFR) gene has
been mapped to chromosomal region 1p36.3 and comprises 11
exons encoding 50, 100-MTHFR (9), a key regulatory enzyme in
folate metabolism that converts 50,100-MTHF to 50-MTHF, the
methyl donor for the remethylation of homocysteine to methio-
nine (10). C677T is a common missense mutation in the gene
that results in the substitution of alanine for valine at amino
acid position 222. The A222V mutation is associated with a 50%
reduction in MTHFR enzymatic activity, which increases plasma
homocysteine and decreases plasma folic acid concentrations (11,
12). The factor V Leiden (FVL) gene is involved in the blood
coagulation; G1691A mutation results in the substitution of gua-
nine with arginine at the amino acid position 506, yielding a
defective FVL protein that is unable to interact with the activated
protein C, which was associated with increased coagulation activ-
ity and susceptibility to thromboembolism in previous studies.
This mutation has also been linked to increased thrombosis risk
and mortality in women following delivery/pregnancy (13, 14).
Numerous studies have found an association between compli-
cations during pregnancy and inherited thrombophilias caused
by mutations in MTHFR and FVL (15–17). However, there have
been no studies to date addressing the potential role of MTHFR
and FVL mutations in the development of GDM in the Indian
population. The objective of this study was to investigate the
extent towhich single amino acid substitutions in theMTHFR and
FVL genes affect the risk of GDM in pregnant women of South
Indian descent.
Materials and Methods
Ethics Statement
The study protocol was approved by the institutional ethics com-
mittee at Kamineni hospitals. Written, informed consent was
obtained from all subjects, who were recruited by a clinical
research midwife.
Study Subjects
This study was carried out in South Indian population from
2007 to 2011. Study subjects were recruited from Kamineni and
Muslim maternity hospitals, Hyderabad. A total of 237 pregnant
women participated in the study; of these, 137 had GDM, and
100 had normal glucose levels during pregnancy (i.e., the non-
GDM group). A diagnosis of GDM was made by analyzing 3mL
of serum samples obtained from each subject; an additional 2mL
of blood was collected and stored in ethylenediamine tetraacetic
acid (EDTA) in order to screen for MTHFR and FVL mutations.
Among GDM patients, 58.4% had a family history of T2DM.
Screening and management of diabetes during pregnancy were
performed by qualified gynecologists according to guidelines set
by the American Diabetes Association (18).
Clinical and Biochemical Analyses
Gestational diabetes mellitus cases were identified using the glu-
cose challenge test between weeks 24 and 28 of gestation; 50 g of
glucose was administered to pregnant women with fasting plasma
glucose levels exceeding 130mg/dL. The oral glucose tolerance
test (OGTT) was then performed using 100 g of glucose follow-
ing an overnight fast and 3 days on an unrestricted diet. Fasting
plasma samples were drawn 1–3 h after glucose administration. In
this study, GDM cases were defined as those whose glucose levels
met or exceeded threshold values described by Khan et al. (19).
Women diagnosed with T1DM, T2DM, or any other form of dia-
betes before pregnancy, were excluded from the study. Body mass
index (BMI) was calculated as weight/height2 (kg/m2). Subjects
with BMI >25 kg/m2 were identified as overweight, while a BMI
>30 kg/m2 was categorized as obese. Blood sampleswere collected
in order to measure the fasting blood sugar (FBS) early in the
morning after overnight fast for more than 10 h and post-prandial
blood glucose (PPBG) levels after 2 h of the FBS.
DNA Extraction and Genotyping
Genomic DNAwas extracted from blood samples stored in EDTA
using previously described methods (20). The DNA was dis-
solved in Tris–EDTA buffer at 100 ng/µL and stored at  80°C
prior to the molecular analysis. C677T (MTHFR) and G1691A
(FVL) mutations were screened using PCR and restriction frag-
ment length polymorphism analysis performed with previously
published primers and restriction enzymes (21) (Table 1). PCR
amplification conditions were as follows; 35 cycles of denaturation
at 95°C for 5min, followed by annealing at 68°C for 30 s (C677T)
or 56°C for 30 s (G1691A), and extension at 72°C for 5min. PCR
products were digested with appropriate restriction enzymes in
a total volume of 20 µL for 16 h at 37°C, and analyzed by 2.5%
agarose gel electrophoresis with ethidium bromide staining.
Statistical Analysis
Hardy–Weinberg equilibrium was calculated in the cases and
controls as described in our prior study (22). Differences between
genotype/allele frequencies of GDM and non-GDM subjects were
calculated using T test. The Yates correction was applied prior to
analyzing genotype frequencies of MTHFR and FVL mutations.
The odds ratio (OR) for genotype/phenotype relations and its 95%
TABLE 1 | Details for genotyping MTHFR and FVL genes.
Gene SNP
location
rs no. Amino acid
substitution
Forward primer Reverse primer Fragment Annealing
temperature
Enzyme
MTHFR Exon 5 rs1801133 Ala 222 Val TGAAGGAGAAGGTGT
CTGCGGGA
GGACGGTGCGGTG
AGAGTG
198bp 68°C HinfI
FVL Exon 10 rs6020 Arg 506 Gln TCAGGCAGGAACAA
CACCAT
GGTTACTTCAAGGACAAAA
TACCTGTAAAGCT
241bp 56°C HindIII
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TABLE 2 | Clinical details of GDM cases and controls.
S. No. Factors GDM (n= 137) Controls (n= 100) p Valuea
1 Age (years) 26:7 5:1 24:6 3:55 0:0001
2 BMI (kg/m2) 26:8 3:93 24:1 3:55 0:28
3 Weight (kg) 69:3 10:18 51:2 6:26 0:0001
4 Mean gestational age (weeks) 24:4 5:0 NA NA
5 FBS (mg/dL) 110:6 3:93 99:24 11:37 <0:0001
6 PPBG (mg/dL) 158:80 47:76 112:00 39:70 0:05
7 Family history 80 (58.4%) 56 (56%) 0:66
8 Insulin/diet therapy (Rx) 81 (59.1%)/56 (40.9%) NA NA
at-Test applies to calculate the p value between GDM and non-GDM subjects.
NA, not analyzed/not applicable, BMI, body mass index; FBS, fasting blood sugar; PPBG, post-prandial blood glucose.
confidence interval (CI)was calculated performing chi-square test
in the cross-tabs procedure for a 2 2 tables using SPSS software.
All statistical analyses were performed using SPSS version 19.0
(SPSS Inc., Chicago, IL, USA).
Results
Characteristics of the Study Population
The clinical characteristics of GDM patients and non-GDM
subjects are listed in Table 2. GDM cases (n= 137) were
aged 22–38 years with a mean age of 26.7 5.1 years, whereas
the age and mean age for controls (n= 137) were 17–34
and 24.6 3.55 years. The pre-pregnancy BMI range was
19.8–35.6 kg/m2 (mean: 26.8 3.93 kg/m2) for GDM and
19–31.1 kg/m2 (mean: 24.1 3.55 kg/m2) for controls (p= 0.28);
40.9% of individuals managed the diabetes with appropriate diet
therapy and exercise, while 59.1% of patients required four to
eight units of insulin therapy over the entire prenatal period.
Age, weight, FBS, and PPBG values differed significantly between
GDM cases and controls (p< 0.05).
C677T Allele and Genotype Frequencies
Genotype and allele frequencies were inHardy–Weinberg equilib-
rium in both groups. The PCR product encompassing the C677T
mutation was 198 bp in length; digestion with HinfI (G#ANTC)
yielded 198 and 175/23 bp fragments representing C and T alleles,
respectively (Figure 1). Genotype frequencies for C677T CC, CT,
and TT among GDM cases were 81.8, 18.2, and 0%, respectively.
The frequencies of the T and C alleles were 9 and 91%. In control
subjects, the frequencies of the CC, CT, and TT genotypes were
82, 18, and 0%, respectively, and C and T allele frequencies were
91 and 9%. Table 3 presents just the distribution of genotypes
and alleles by GDM status. There was no evidence of a dis-
ease association for any of the allelic or genotype classes (OR:
-1.015; 95% CI= 0.5378–1.916; p= 0.8892 and OR: -1.011; 95%
CI= 0.5211–1.961; p= 0.9746).
G1691A Allele and Genotype Frequencies
A 241-bp PCR product encompassing the G1691A mutation was
digested with HindIII (A#AGCTT), yielding a 209-bp fragment
indicating the presence of the A allele (Figure 2). Only the GG
(100%) genotype was observed in both cases and controls; there-
fore, this locus was not further analyzed.
FIGURE 1 | Three percent agarose gel consist of digested products of
C677T mutation. It represents the 3% agarose gel picture. Lane 1 consists
of 100 bp ladder. Lanes 2–10 consist of homozygous CC genotypes and lane
11 consists of heterozygous CT genotype.
TABLE 3 | Allele and genotype frequencies in GDM cases and controls for
MTHFR gene.
Genotype and allele GDM cases
(n= 137)
Controls
(n= 100)
p Valuea
MTHFR (rs1801133)
N (%) N (%)
CC 112 (81:8) 82 (82) 0.96a
CT 25 (18:2) 18 (18)
TT 0 (0) 0 (0)
C 249 (0:09) 182 (91) 0.96a
T 25 (0:09) 18 (9)
aChi-square p value.
Discussion
This study investigated whether C677T and G1691A mutations
are associated with the development of GDM among individ-
uals of South Indian descent by genotyping age-matched cases
and pregnant non-GDM subjects. The results did not reveal any
association between investigated mutations and GDM risk in this
study population.
Hyperglycemia is associated with an increased risk of unfavor-
able outcome in adults (T2DM), children (T1DM), and pregnant
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FIGURE 2 | Digested products appeared on 3% agarose gel for
evaluation of FVL (G1691A) mutation. Digested PCR products run on 3%
agarose gel. Lane 1 represents 100bp DNA ladder. Lanes 2–5 represent
homozygous GG genotypes.
women (GDM) (23). MTHFR and FVL gene mutations are
considered risk factors for hereditary thrombophilia and may
influence the development of complications during pregnancy
(24). We sought to determine whether C677T and G1691A
mutations are associated with altered glucose levels during preg-
nancy, which could indicate GDM risk. Cases and controls dif-
fered significantly in terms of age, weight, FBS, and PPBG, but
not with respect to genotype frequencies at either locus. These
results suggest that the C677T and G1691A mutations are not
involved in the development of GDM during pregnancy in Indian
population.
The frequency of MTHFR gene mutations varies across geo-
graphical and ethnic groups. For example, the frequency of C677T
in T2DM cases fluctuates between 40 and 49%, depending on the
ethnicity of the study cohort (India, 40%; Turkey, 49%; Tunisia,
45%; Brazil, 46%; and China, 44%) (25–29). The C677T geno-
type frequencies (CC and CT) between north (25) and South
Indian populations in T2DM and GDM subjects are varied. Both
environmental and genetic factors contribute to the development
and progression of GDM during pregnancy; this work showed
that MTHFR mutations have no role in GDM in South Indian
population.
The prior report from Australian population confirmed that
16.6%womenharboring theMTHFRC677T genemutation devel-
oped at least one pregnancy complication; however, the effect was
restricted to women with small for gestational age (SGA) infants.
There were no differences in genotype distribution amongwomen
with intrauterine fetal death, pre-eclampsia, or preterm delivery,
and the study concluded that the mutation was a genetic marker
for identifying women who are at increased risk of having an SGA
infant (30).
Diabetes is a risk factor for thrombotic events (31) and
atherothrombosis (32). The pathogenesis of diabetes involves
hypercoagulability of the blood due to several factors such as
the non-enzymatic glycosylation of clotting inhibitors. Patients
who are carriers of a thrombophilic gene variant (e.g., factor V
A1691G andnor prothrombin A20210G) or other thrombotic risk
factors are susceptible to the inherited or acquired thrombophilia.
FVLmutations lead to a thrombophilic condition that is heritable
both in hetero- and homozygous forms (33). Several previous
studies have investigated a potential relationship between FVL
gene mutations and diabetes incidence, and there is one report of
a possible co-segregation of FVL and T2DM risk alleles (34).
A prevalence of 4.6% for the A allele of FVL G1691A (rs6020)
has been reported among coronary artery disease patients with
T2DM (35). In a later study, these authors reported prevalence
rates for this mutation of 3.2, 1.6, and 4.9% among Iranian T2DM
patients, T2DM patients with microalbuminuria, and normoal-
buminuric T2DM patients, respectively, suggesting that the FVL
G1691Amutation is not associated withmicroalbuminuria in this
population (14). This mutation has also been implicated in the
pathogenesis of thrombosis (36).
No association was found between FVL mutations and T2DM
among Lebanese (36), Dutch (37), Japanese (38), and Caucasian
patients (39).
In conclusion,MTHFR (C677T) and FVL (G1691A) mutations
are not likely to be genetic risk factors for the development of
GDM in South Indian women.
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